Market Overview

UPDATE: Wunderlich Securities Reiterates Buy Rating, Raises PT on Denbury Resources

Share:
Related DNR
Mid-Afternoon Market Update: Arrowhead Pharma Tumbles Following EX-1 RNAi Program Discontinuations; Arbutus Biopharma Shares Surge
18 Biggest Mid-Day Gainers For Wednesday
Denbury Resources Continues To Tread Water (Seeking Alpha)

In a report published Monday, Wunderlich Securities reiterated its Buy rating on Denbury Resources (NYSE: DNR), and raised its price target from $18.00 to $22.00.

Wunderlich Securities noted, “Denbury Resources, Inc. (DNR) announced last week that it would monetize its Williston Basin assets for interests in two mature oil fields and $1.6 billion to Exxon Mobil Corporation (XOM-NR). Denbury also increased its CO2 exposure in the Rocky Mountains and is negotiating for an interest in Exxon Mobil's LaBarge Field. We like these moves by Denbury as it allows them to unlock the value of the Williston assets, improve the financial position and return the company to one solely focused on tertiary oil recovery.”

Denbury Resources closed on Friday at $17.36.

Latest Ratings for DNR

DateFirmActionFromTo
Aug 2016BarclaysDowngradesEqual-WeightUnderweight
Jun 2016Stifel NicolausUpgradesSellHold
Apr 2016KeyBancInitiates Coverage onSector Perform

View More Analyst Ratings for DNR
View the Latest Analyst Ratings

Posted-In: Wunderlich SecuritiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (DNR)

View Comments and Join the Discussion!